Fundraising Fox
/Companies
Sign in

Cortene

1 known investors

Find your way into Cortene

Sign up to see every warm intro you have to Cortene

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cortene team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Cortene is developing a patent-protected, peptide-based drug targeting the brain signaling believed to underlie acquired chronic diseases such as Parkinson's, Alzheimer's, dysautonomia, autoimmunity, and ME/CFS. The company operates in biotech, focusing on the root causes of brain-centric chronic conditions.

BiotechHealthtech

Founders & leadership

GP
Gerard PereiraFounder, President & CEOFounder, President & CEO at Corteneinc
SCSanjay Chanda
Sanjay ChandaChief Development OfficerChief Development Officer at Corteneinc
MCMichael Corbett
Michael CorbettChief Business OfficerMichael Corbett brings enterprise software architecture and business analysis expertise, with a background implementing large-scale applications across CRM, business intelligence, and system integration platforms including Salesforce and Cognos.

Investors · 1

Related companies · 2

1MgThis is a product listing page on an online pharmacy for Tugain Twins 5 Solution, a topical minoxidil-based medicine sold to treat hair loss and promote hair regrowth. The page provides usage instructions, benefits, side effects, and purchase/return details rather than describing a company.
CleneClene is a clinical-stage biopharmaceutical company developing nanotherapeutics that target cellular energy impairments to treat neurodegenerative diseases and restore neuronal health. Its platform produces clean-surfaced, catalytically-active nanocrystals for therapeutic use.

Companies working in the same space as Cortene.

Frequently asked questions

What does Cortene do?
Cortene is developing a patent-protected, peptide-based drug targeting the brain signaling believed to underlie acquired chronic diseases such as Parkinson's, Alzheimer's, dysautonomia, autoimmunity, and ME/CFS. The company operates in biotech, focusing on the root causes of brain-centric chronic conditions.
Who founded Cortene?
Cortene was founded by Gerard Pereira.
Who are Cortene's investors?
Cortene's investors include Lauder Partners.